Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 797 Views
-
Last post by NHE
-
- 0 Replies
- 2172 Views
-
Last post by frodo
-
- 0 Replies
- 1080 Views
-
Last post by NHE
-
- 0 Replies
- 1306 Views
-
Last post by frodo
-
- 1 Replies
- 1000 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1562 Views
-
Last post by NHE
-
- 0 Replies
- 1999 Views
-
Last post by vesta
-
- 1 Replies
- 1120 Views
-
Last post by Petr75